Ward Keith Wayne Insider Trades

Insider Trading History

Track insider trading activity for Ward Keith Wayne. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $27k 35,000 shares
Last Trade
Feb 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$510k 35,000 shares
$14.56
$0.77
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $15.4k 20,001 shares
Last Trade
Nov 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.7k 14,110 shares
$1.75
$0.77
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $1.13M 1,472,692 shares
Last Trade
Aug 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.9k 1,472,692 shares
$0.01
$0.77
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $193k 250,000 shares
Last Trade
Jan 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.15k 250,000 shares
$0.02
$0.77
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $193k 250,000 shares
Last Trade
Dec 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15k 250,000 shares
$0.06
$0.77
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $4.34M 25,184 shares
Last Trade
Feb 26, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.32M 25,184 shares
$91.99
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $5.83M 33,804 shares
Last Trade
Feb 26, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.32M 25,184 shares
$91.99
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $2.93M 16,987 shares
Last Trade
Feb 26, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.3M 25,184 shares
$91.21
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $13.1M 76,150 shares
Last Trade
Feb 26, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.32M 25,184 shares
$91.99
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Feb 26, 2019 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.32M 25,184 shares
$91.99
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $16M 92,967 shares
Last Trade
Feb 25, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.36M 15,183 shares
$89.62
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $1.49M 8,620 shares
Last Trade
Feb 25, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.38M 15,183 shares
$91.00
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $2.62M 15,183 shares
Last Trade
Feb 25, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.36M 15,183 shares
$89.62
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $4.1M 23,803 shares
Last Trade
Feb 25, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.36M 15,183 shares
$89.62
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $715k 4,150 shares
Last Trade
Jan 31, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$331k 4,150 shares
$79.77
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $1.44M 8,367 shares
Last Trade
Jan 31, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$331k 4,150 shares
$79.77
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jan 31, 2019 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$331k 4,150 shares
$79.77
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $1.96M 11,370 shares
Last Trade
Jan 31, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$318k 4,150 shares
$76.70
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $2.2M 12,770 shares
Last Trade
Jan 31, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$331k 4,150 shares
$79.77
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jan 14, 2019 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$613k 8,620 shares
$71.15
$172.36

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up